Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer.

导出 OA

翻译打印收藏纠错

作者： Annika,Kohvakka ^[1] ; Mina,Sattari ^[1] ; Janika,Nättinen ^[2] ; Ulla,Aapola ^[2] ; Pavlína,Gregorová ^[3] ; Teuvo L J,Tammela ^[4] ; Hannu,Uusitalo ^[5] ; L Peter,Sarin ^[6] ; Tapio,Visakorpi ^[7] ; Leena,Latonen ^[8]

作者单位： Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, 33520, Tampere, Finland. ^[1] Eye and Vision Research Group, Faculty of Medicine and Health Technology, Tampere University, 33520, Tampere, Finland. ^[2] RNAcious Laboratory, Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, 00014, Helsinki, Finland. ^[3] Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, 33520, Tampere, Finland.;Department of Urology, Tampere University Hospital, Tampere, Finland. ^[4] Eye and Vision Research Group, Faculty of Medicine and Health Technology, Tampere University, 33520, Tampere, Finland.;Tays Eye Centre, Tampere University Hospital, 33520, Tampere, Finland. ^[5] RNAcious Laboratory, Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, 00014, Helsinki, Finland.;HiLIFE Helsinki Institute of Life Science, University of Helsinki, 00014, Helsinki, Finland. ^[6] Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, 33520, Tampere, Finland. tapio.visakorpi@tuni.fi.;Fimlab Laboratories Ltd, Tampere University Hospital, 00014, Tampere, Finland. tapio.visakorpi@tuni.fi. ^[7] Institute of Biomedicine, University of Eastern Finland, 70211, Kuopio, Finland. leena.latonen@uef.fi. ^[8]